Caveolae and caveolin-3 in muscular dystrophy

Trends in Molecular Medicine

Volumn 7, Issue 10, 2001, Pages 435-441

  Galbiati, Ferruccio ^a   Razani, Babak ^b   Lisanti, Michael P ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CREATINE KINASE; DYSTROPHIN; GLYCOPROTEIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1;

CAVEOLA; CHROMOSOME 3P; DUCHENNE MUSCULAR DYSTROPHY; GENE MUTATION; HEART MUSCLE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MEMBRANE VESICLE; MUSCLE DISEASE; MUSCLE TUMOR; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE;

EID: 0034792435     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02105-0     Document Type: Review

References (52)

1. Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer's disease, and muscular dystrophy
2. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus
3. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in RSV-transformed fibroblasts
4. Caveolin, a protein component of caveolae membrane coats
5. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle
6. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo
7. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: Implications for the biogenesis of caveolae
8. Induction of caveolae in the apical plasma membrane of Madin-Darby canine kidney cells
9. Caveolin-1 and -2 in the exocytic pathway of MDCK cells
10. Caveolae, caveolin and caveolin-rich membrane domains: A signalling hypothesis
11. Emerging themes in lipid rafts and caveolae
12. Caveolins, a family of scaffolding proteins for organizing 'pre-assembled signaling complexes' at the plasma membrane
13. Oligomeric structure of caveolin: Implications for caveolae membrane organization
14. Expression and characterization of recombinant caveolin: Purification by poly-histidine tagging and cholesterol-dependent incorporation into defined lipid membranes
15. VIP21/caveolin is a cholesterol-binding protein
16. Evidence for a regulated interaction between hetero-trimeric G proteins and caveolin
17. Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes
18. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for caveolae localization
19. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins
20. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro
21. Identification, sequence and expression of caveolin-2 defines a caveolin gene family
22. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: Functional significance of the NOS caveolin binding domain in vivo
23. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain
24. Localization of the insulin receptor in caveolae of adipocyte plasma membrane
25. Caveolin is an activator of insulin receptor signaling
26. Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes: Dynamic regulation by extracellular glucose and intracellular metabolites
27. Caveolin-3 associates with developing T-tubules during muscle differentiation
28. Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle
29. Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members
30. Caveolin-3 is not an essential component of the dystrophin glycoprotein complex
31. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts
32. Freeze-fracture studies of muscle caveolae in human muscular dystrophy
33. Increased caveolin-3 levels in mdx mouse muscles
34. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy
35. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation
36. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy
37. The limb-girdle muscular dystrophies - Multiple genes, multiple mechanisms
38. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
39. Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans: Implications for the molecular evolution of mammalian caveolin genes
40. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the Golgi complex
41. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutants and rescues wild-type caveolin-3
42. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy
43. Caveolin-3 in muscular dystrophy
44. Mutations in the caveolin-3 gene: When are they pathogenic?
45. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia
46. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease
47. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype
48. Caveolin-3 deficiency causes muscle degeneration in mice
49. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities
50. Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity
51. Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
52. Invasion activating caveolin-1 mutation in human scirrhous breast cancers